309 related articles for article (PubMed ID: 18990511)
1. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer.
Choi CW; Cho CK; Yoo SY; Kim MS; Yang KM; Yoo HJ; Seo YS; Kang JK; Lee DH; Lee KH; Lee ED; Rhu SY; Choi SC; Kim MH; Kim BJ
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):147-53. PubMed ID: 18990511
[TBL] [Abstract][Full Text] [Related]
2. Multivariate analysis of para-aortic lymph node recurrence after definitive radiotherapy for stage IB-IVA squamous cell carcinoma of uterine cervix.
Huang EY; Wang CJ; Chen HC; Fang FM; Huang YJ; Wang CY; Hsu HC
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):834-42. PubMed ID: 18439764
[TBL] [Abstract][Full Text] [Related]
3. Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.
Salazar OM; Sandhu TS; Lattin PB; Chang JH; Lee CK; Groshko GA; Lattin CJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):707-15. PubMed ID: 18455322
[TBL] [Abstract][Full Text] [Related]
4. Impact of surgical staging in women with locally advanced cervical cancer.
Goff BA; Muntz HG; Paley PJ; Tamimi HK; Koh WJ; Greer BE
Gynecol Oncol; 1999 Sep; 74(3):436-42. PubMed ID: 10479506
[TBL] [Abstract][Full Text] [Related]
5. Nodal distribution and its significance in FIGO stage IIIc endometrial cancer.
McMeekin DS; Lashbrook D; Gold M; Scribner DR; Kamelle S; Tillmanns TD; Mannel R
Gynecol Oncol; 2001 Aug; 82(2):375-9. PubMed ID: 11531298
[TBL] [Abstract][Full Text] [Related]
6. A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions.
Milano MT; Katz AW; Muhs AG; Philip A; Buchholz DJ; Schell MC; Okunieff P
Cancer; 2008 Feb; 112(3):650-8. PubMed ID: 18072260
[TBL] [Abstract][Full Text] [Related]
7. Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results.
Liang JA; Chen SW; Chang WC; Hung YC; Yeh LS; Yang SN; Lin FJ
Clin Oncol (R Coll Radiol); 2008 Nov; 20(9):683-90. PubMed ID: 18676129
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer.
Guckenberger M; Bachmann J; Wulf J; Mueller G; Krieger T; Baier K; Richter A; Wilbert J; Flentje M
Radiother Oncol; 2010 Jan; 94(1):53-9. PubMed ID: 20079550
[TBL] [Abstract][Full Text] [Related]
9. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
[TBL] [Abstract][Full Text] [Related]
10. Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary.
Hauswald H; Lindel K; Rochet N; Debus J; Harms W
Strahlenther Onkol; 2008 Mar; 184(3):150-6. PubMed ID: 18330511
[TBL] [Abstract][Full Text] [Related]
11. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim H; Kim W; Lee M; Song E; Loh JJ
Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiation therapy in patients with pelvic recurrence from rectal carcinoma.
Kim MS; Choi C; Yoo S; Cho C; Seo Y; Ji Y; Lee D; Hwang D; Moon S; Kim MS; Kang H
Jpn J Clin Oncol; 2008 Oct; 38(10):695-700. PubMed ID: 18723850
[TBL] [Abstract][Full Text] [Related]
13. High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
Kim YS; Kim JH; Ahn SD; Lee SW; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1522-8. PubMed ID: 19231106
[TBL] [Abstract][Full Text] [Related]
14. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
Parker K; Gallop-Evans E; Hanna L; Adams M
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
[TBL] [Abstract][Full Text] [Related]
15. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
[TBL] [Abstract][Full Text] [Related]
16. Para-aortic lymph node recurrence in patients with cervical cancer treated with postoperative irradiation to the pelvis.
Takahashi M; Mitsuhashi N; Sakurai H; Hayakawa K; Niibe H
Anticancer Res; 1997; 17(3C):2265-8. PubMed ID: 9216699
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer.
Akyurek S; Chang EL; Mahajan A; Hassenbusch SJ; Allen PK; Mathews LA; Shiu AS; Maor MH; Woo SY
Am J Clin Oncol; 2007 Jun; 30(3):310-4. PubMed ID: 17551311
[TBL] [Abstract][Full Text] [Related]
18. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
19. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
[TBL] [Abstract][Full Text] [Related]
20. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
Rusthoven KE; Kavanagh BD; Cardenes H; Stieber VW; Burri SH; Feigenberg SJ; Chidel MA; Pugh TJ; Franklin W; Kane M; Gaspar LE; Schefter TE
J Clin Oncol; 2009 Apr; 27(10):1572-8. PubMed ID: 19255321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
